The Armenian National Institute (ANI) announced the launch of a new website documenting the unfolding of the genocidal process that resulted in the destruction of the Nagorno-Karabakh Republic. […] ...

Fans can purchase tickets for all upcoming ‘Unprecedented S—‘ shows on sites like Vivid Seats; the official on-sale is Friday ...

Google Chrome is rolling out a new feature designed to help users manage their notifications more effectively. The latest update brings an “Instant Unsubscribe” option directly within notifications, ...

About Alimera Sciences, Inc. Alimera Sciences is a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining ...

ANI Pharmaceuticals, Inc. (NASDAQ ... on bringing online the significant capacity expansion at our New Jersey site and believe all 15 new manufacturing suites and the new QC lab will be fully ...

On June 24, ANI said it was buying Alimera Sciences for $5.50 per share in cash, in a deal that valued Alimera at $381 million. The offer represented a 75% premium to its closing share price of $3.15 ...

ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (“ANI” or the “Company”) announced today that the Company has initiated closing logistics for the previously announced acquisition of Alimera Sciences, Inc.

© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...

Singer, songwriter, author and Broadway performer Ani DiFranco is embarking on a tour in 2025 to support her new album, “Unprecedented Sh!t.” The tour includes two stops in Pa. - Sunday ...

Police discovered a suspicious bag, near the site of a major political rally in Islamabad on Sunday in Sangjani, Islamabad, ...

ANI is focused on delivering sustainable growth ... Investor and/or Media Contacts: Lisa M. Wilson, In-Site Communications, Inc. 212-452-2793 [email protected] ...

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) (“ANI”) and Alimera Sciences, Inc. (NASDAQ: ALIM) (“Alimera” or the “Company”) today jointly announced that they have scheduled the closing of ...